According to the agreement, Ypsomed will have the exclusive right to promote, advertise, market, distribute and sell the OmniPod System in eleven countries covered by the agreement, beginning in Germany, France and the United Kingdom in June of 2010. Ypsomed expects to introduce the OmniPod System to Switzerland, the Netherlands, Belgium, the Nordic countries and Australia in the second half of 2010 and in China in the first half of 2011.

"We at Ypsomed are excited and proud to have been selected by Insulet as their exclusive distribution partner for the OmniPod System," said Simon Michel, Senior Vice President Marketing and Sales of Ypsomed. "We are highly motivated to launch the OmniPod System in Europe and other countries around the world under the mylife(TM) diabetes care brand. The OmniPod System is an innovative and attractive extension to our mylife(TM) product portfolio. We expect that over 200 Ypsomed employees will be involved in the promotion, marketing, distribution and sale of the OmniPod System."

SOURCE Insulet Corporation